Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Hart, E P ‘T"'
Autor:
Gregory, Sarah, Long, Jeffrey D, Klöppel, Stefan, Razi, Adeel, Scheller, Elisa, Minkova, Lora, Johnson, Eileanoir B, Durr, Alexandra, Roos, Raymund A C, Leavitt, Blair R, Mills, James A, Stout, Julie C, Scahill, Rachael I, Tabrizi, Sarah J, Rees, Geraint, Coleman, A, Decolongon, J, Fan, M, Koren, T, Leavitt, B, Durr, A, Jauffret, C, Justo, D, Lehericy, S, Nigaud, K, Valabrègue, R, Roos, R, Hart, E P ‘T, Schoonderbeek, A, Berna, C, Crawford, H, Ghosh, R, Hensman, D, Johnson, E, McColgan, P, Papoutsi, M, Read, J, Owen, G, Craufurd, D, Reilmann, R, Weber, N, Labuschagne, I, Landwehrmeyer, B, Orth, M
Publikováno v:
Gregory, Sarah; Long, Jeffrey D; Klöppel, Stefan; Razi, Adeel; Scheller, Elisa; Minkova, Lora; Johnson, Eileanoir B; Durr, Alexandra; Roos, Raymund A C; Leavitt, Blair R; Mills, James A; Stout, Julie C; Scahill, Rachael I; Tabrizi, Sarah J; Rees, Geraint; Coleman, A; Decolongon, J; Fan, M; Koren, T; Leavitt, B; ... (2018). Testing a longitudinal compensation model in premanifest Huntington’s disease. Brain, 141(7), pp. 2156-2166. Oxford University Press 10.1093/brain/awy122
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7252054eabf5618ee8130576774da380
https://boris.unibe.ch/116919/1/awy122.pdf
https://boris.unibe.ch/116919/1/awy122.pdf
Autor:
McColgan P; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom., Gregory S; Wellcome Trust Centre for Neuroimaging UCL Institute of Neurology London WC1N 3BG United Kingdom., Razi A; Wellcome Trust Centre for Neuroimaging UCL Institute of Neurology London WC1N 3BG United Kingdom; Department of Electronic Engineering NED University of Engineering and Technology Karachi Pakistan., Seunarine KK; Developmental Imaging and Biophysics Section UCL Institute of Child Health London WC1N 1EH United Kingdom., Gargouri F; APHP Department of Genetics Groupe Hospitalier Pitié-Salpêtrière and ICM (Brain and Spine Institute) INSERM U1127 CNRS UMR 7225 Sorbonne Universités - UPMC Université Paris VI UMR_S 1127 Paris France., Durr A; APHP Department of Genetics Groupe Hospitalier Pitié-Salpêtrière and ICM (Brain and Spine Institute) INSERM U1127 CNRS UMR 7225 Sorbonne Universités - UPMC Université Paris VI UMR_S 1127 Paris France., Roos RA; Department of Neurology Leiden University Medical Centre Leiden 2300RC The Netherlands., Leavitt BR; Department of Medical Genetics Centre for Molecular Medicine and Therapeutics University of British Columbia 950 West 28th Avenue Vancouver BC V5Z 4H4 Canada., Scahill RI; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom., Clark CA; Developmental Imaging and Biophysics Section UCL Institute of Child Health London WC1N 1EH United Kingdom., Tabrizi SJ; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom; National Hospital for Neurology and Neurosurgery Queen Square London WC1N 3BG United Kingdom., Rees G; Wellcome Trust Centre for Neuroimaging UCL Institute of Neurology London WC1N 3BG United Kingdom., Coleman A; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom., Decolongon J; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom., Fan M; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom., Petkau T; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom., Jauffret C; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom., Justo D; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom., Lehericy S; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom., Nigaud K; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom., Valabrègue R; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom., Choonderbeek A; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom., Hart EP; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom., Hensman Moss DJ; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom., Crawford H; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom., Johnson E; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom., Papoutsi M; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom., Berna C; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom., Reilmann R; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom., Weber N; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom., Stout J; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom., Labuschagne I; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom., Landwehrmeyer B; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom., Orth M; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom., Johnson H; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom.
Publikováno v:
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2017 Jan 16; Vol. 4 (2), pp. 106-118. Date of Electronic Publication: 2017 Jan 16 (Print Publication: 2017).
